Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02907918
Title Neoadjuvant Study of Palbociclib in Combination With Letrozole and Trastuzumab in Stage II-III ER+ HER2+ Breast Cancer (PALTAN)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine

Her2-receptor positive breast cancer



Letrozole + Palbociclib + Trastuzumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.